Qin-Hai Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Qin-Hai Shen has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Zhao-Min Qin
Department of Nursing, Shandong Medical College, Jinan, Shandong, China
2 shared publicationsGuang-Wei Liu
Department of Gastroenterology, The First Affiliated Hospital, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China
1 shared publicationMeng-Hui Zhang
Department of General Surgery, The Fourth Hospital of Jinan, Jinan, Shandong 250031, P.R. China
1 shared publicationQiao-Ling Wang
Department of Ophthalmology, The Second Hospital of Jinan, Jinan, Shandong 250022, P.R. China
1 shared publicationXi Chen
Department of Ophthalmology, The Ninth Hospital of Chongqing, Chongqing 400700, P.R. China
1 shared publication
Latest Publications
- 6 December 2017
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 20 (4) , 617-625
An ensemble method integrated with miRNA expression data for predicting miRNA targets in stomach adenocarcinoma
OBJECTIVE: It is crucially important to discover the relationships between genes and microRNAs (miRNAs) in cancer. Thus, we proposed a combined bioinformatics method integrating Pearson’s correlation coefficient (PCC), Lasso, and causal inference met
- 6 December 2017
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 20 (4) , 617-625
An ensemble method integrated with miRNA expression data for predicting miRNA targets in stomach adenocarcinoma
OBJECTIVE: It is crucially important to discover the relationships between genes and microRNAs (miRNAs) in cancer. Thus, we proposed a combined bioinformatics method integrating Pearson’s correlation coefficient (PCC), Lasso, and causal inference met
- Open Access
- 23 August 2016
- Published by Spandidos Publications in Oncology Letters
- Vol. 12 (5) , 3285-3295
Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma
The objective of the present study is to identify significant genes and pathways associated with hepatocellular carcinoma (HCC) by systematically tracking the dysregulated modules of re-weighted protein-protein interaction (PPI) networks. Firstly, normal and HCC PPI networks were inferred and re-weighted based on Pearson correlation coefficient. Next, modules in the PPI networks were explored by a clique-merging algorithm, and disrupted modules were identified utilizing a maximum weight bipartite matching in non-increasing order. Then, the gene compositions of the disrupted modules were studied and compared with differentially expressed (DE) genes, and pathway enrichment analysis for these genes was performed based on Expression Analysis Systematic Explorer. Finally, validations of significant genes in HCC were conducted using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. The present study evaluated 394 disrupted module pairs, which comprised 236 dysregulated genes. When the dysregulated genes were compared with 211 DE genes, a total of 26 common genes [including phospholipase C beta 1, cytochrome P450 (CYP) 2C8 and CYP2B6] were obtained. Furthermore, 6 of these 26 common genes were validated by RT-qPCR. Pathway enrichment analysis of dysregulated genes demonstrated that neuroactive ligand-receptor interaction, purine and drug metabolism, and metabolism of xenobiotics mediated by CYP were significantly disrupted pathways. In conclusion, the present study greatly improved the understanding of HCC in a systematic manner and provided potential biomarkers for early detection and novel therapeutic methods.
- 23 August 2016
- Published by Spandidos Publications in Oncology Letters
- Vol. 12 (5) , 3285-3295
Open AccessSystematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma
The objective of the present study is to identify significant genes and pathways associated with hepatocellular carcinoma (HCC) by systematically tracking the dysregulated modules of re-weighted protein-protein interaction (PPI) networks. Firstly, normal and HCC PPI networks were inferred and re-weighted based on Pearson correlation coefficient. Next, modules in the PPI networks were explored by a clique-merging algorithm, and disrupted modules were identified utilizing a maximum weight bipartite matching in non-increasing order. Then, the gene compositions of the disrupted modules were studied and compared with differentially expressed (DE) genes, and pathway enrichment analysis for these genes was performed based on Expression Analysis Systematic Explorer. Finally, validations of significant genes in HCC were conducted using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. The present study evaluated 394 disrupted module pairs, which comprised 236 dysregulated genes. When the dysregulated genes were compared with 211 DE genes, a total of 26 common genes [including phospholipase C beta 1, cytochrome P450 (CYP) 2C8 and CYP2B6] were obtained. Furthermore, 6 of these 26 common genes were validated by RT-qPCR. Pathway enrichment analysis of dysregulated genes demonstrated that neuroactive ligand-receptor interaction, purine and drug metabolism, and metabolism of xenobiotics mediated by CYP were significantly disrupted pathways. In conclusion, the present study greatly improved the understanding of HCC in a systematic manner and provided potential biomarkers for early detection and novel therapeutic methods.